UAB "PHARMACON" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 257,096 |
| 110,817 |
| 58,380 |
| 55,467 |
| 23,908 |
| 66.73 |
| 21.57 |
| 111,710 |
| 32,522 |
| 4,685 |
| 139,547 |
| 2024 |
|---|
| 247,077 |
| 67,323 |
| 18,693 |
| 17,879 |
| 4,872 |
| 62.92 |
| 7.24 |
| 129,590 |
| 34,088 |
| 2,751 |
| 160,927 |
| 2025 |
|---|
| 218,515 |
| 56,610 |
| 37,848 |
| 35,574 |
| 9,216 |
| 59.83 |
| 16.28 |
| 165,164 |
| 16,076 |
| 1,546 |
| 179,694 |
Register and
explore Okredo data| 2025 |
|---|
| 218,515 |
| 56,610 |
| 37,848 |
| 35,574 |
| 9,216 |
| 59.83 |
| 16.28 |
| 165,164 |
| 16,076 |
| 1,546 |
| 179,694 |
Register and
explore Okredo dataTurnover (€)
2025
Turnover (€)
218,515 €-12 % *
Sales per employee (€)
56,610 €-16 % *
Profit before tax (€)
37,848 €102 % *
Net Profit (€)
35,574 €99 % *
Profit per employee (€)
9,216 €89 % *
Total profitability (%)
59.83 %-4.91 % *
Net profitability (%)
16.28 %124.86 % *
Equity (€)
165,164 €27 % *
Amounts Payable And Liabilities (€)
16,076 €-53 % *
Non-current Assets (€)
1,546 €-44 % *
CurrentAssets (€)
179,694 €12 % *
